Anti-AKT1 抗体 [1F7E10]
Anti-AKT1 antibody [1F7E10]
- Lab Essentials
- 詳細を見る
Be the first to review this product! Submit a review
|
(12 Publications)
Mouse Monoclonal AKT1 antibody. Suitable for Flow Cyt, WB, ICC/IF and reacts with Human, Mouse, Rat, African green monkey, Recombinant fragment - Human, Transfected cell lysate - Human samples. Cited in 12 publications. Immunogen corresponding to Recombinant Fragment Protein within Human AKT1 aa 1-150.
別名を表示する
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-AKT1 antibody [1F7E10] (AB233755)
Flow cytometric analysis of HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling AKT1 with ab233755 at 1/200 dilution (green) compared with a negative control (red).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-AKT1 antibody [1F7E10] (AB233755)
HepG2 (human liver hepatocellular carcinoma cell line) cells stained for AKT1 (green) using ab233755 in ICC/IF. Blue : DRAQ5 DNA dye. Red : Actin filaments stained with AlexaFluor®-555-Phalloidin.
- WB
Lab
Western blot - Anti-AKT1 antibody [1F7E10] (AB233755)
Anti-AKT1 antibody [1F7E10] (ab233755) staining at 1/500 dilution, shown in green; Rabbit anti-6x His Tag ( ab9108) loading control staining at 1/1000 dilution, shown in magenta. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20,000 dilution.
Please note this antibody has weak cross reactivity with AKT2 and AKT3.
All lanes:
Western blot - Anti-AKT1 antibody [1F7E10] (ab233755) at 1/500 dilution
Lane 1:
Western blot - Recombinant human AKT1 protein (His tag N-Terminus) (<a href='/products/proteins-peptides/recombinant-human-akt1-protein-ab79792'>ab79792</a>) at 0.2 µg
Lane 2:
Western blot - Recombinant human AKT2 protein (His tag N-Terminus) (<a href='/products/proteins-peptides/recombinant-human-akt2-protein-ab79798'>ab79798</a>) at 0.2 µg
Lane 3:
Western blot - Recombinant human AKT3 protein (His tag N-Terminus) (<a href='/products/proteins-peptides/recombinant-human-akt3-protein-ab79799'>ab79799</a>)
Secondary
All lanes:
Goat anti-Mouse 800CW & Goat anti-Rabbit 680RD at 1/20000 dilution
Predicted band size: 56 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT1 antibody [1F7E10] (AB233755)
All lanes:
Western blot - Anti-AKT1 antibody [1F7E10] (ab233755) at 1/500 dilution
Lane 1:
HEK-293 (human epithelial cell line from embryonic kidney) whole cell lysate
Lane 2:
AKT1 (aa 1-150)-hIgGFc transfected HEK-293 whole cell lysate
Predicted band size: 55 kDa
true
- WB
Supplier Data
Western blot - Anti-AKT1 antibody [1F7E10] (AB233755)
All lanes:
Western blot - Anti-AKT1 antibody [1F7E10] (ab233755) at 1/500 dilution
Lane 1:
MCF7 (human breast adenocarcinoma cell line) whole cell lysate
Lane 2:
NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate
Lane 3:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
Lane 4:
COS-7 (African green monkey kidney fibroblast-like cell line) whole cell lysate
Lane 5:
C6 (rat glial tumor cell line) whole cell lysate
Predicted band size: 55 kDa
true
- WB
Supplier Data
Western blot - Anti-AKT1 antibody [1F7E10] (AB233755)
Expected recombinant MW is 44 kDa.
All lanes:
Western blot - Anti-AKT1 antibody [1F7E10] (ab233755) at 1/500 dilution
All lanes:
Recombinant human AKT1 (aa 1-150) protein
Predicted band size: 55 kDa
true
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT1 regulates a broad spectrum of cellular functions through signaling pathways. It is an important player in the phosphatidylinositol 3-kinase (PI3K) and AKT pathway forming part of a complex involved in promoting cell survival and growth. AKT1 interacts closely with other proteins such as mTOR influencing cellular metabolism and autophagy. The phosphorylation state of AKT1 is critical for its activity with modifications like p-AKT S473 impacting its interaction with cellular substrates.
Pathways
AKT1 participates in the PI3K/AKT/mTOR signaling cascade instrumental in cell proliferation and metabolism. AKT1 integrates signals from insulin and growth factors modulating pathways that control cell growth and glucose uptake. This pathway involves proteins like mTOR and phospho-AKT which coordinate cellular responses to external stimuli. AKT1’s phosphorylation at serine 473 and the involvement of AKT1 E17K a gain-of-function mutation influence these pathways significantly.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (12)
Recent publications for all applications. Explore the full list and refine your search
Cell communication and signaling : CCS 23:194 PubMed40269955
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 25:2392339 PubMed39155507
2024
Applications
Unspecified application
Species
Unspecified reactive species
Physiological research 73:105-115 PubMed38466009
2024
Applications
Unspecified application
Species
Unspecified reactive species
Histology and histopathology 39:1149-1157 PubMed38275076
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Korean journal of internal medicine 38:393-405 PubMed37157174
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neuropathology : official journal of the Japanese Society of Neuropathology 43:362-372 PubMed36918198
2023
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 8:e11279 PubMed36387579
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35806255
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 10:139 PubMed35284536
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2021:5536679 PubMed34925530
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com